Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

10 Feb 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 4503.T


Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive... (more)


Beta: 0.68
Market Cap(Mil.): ¥3,507,148.00
Shares Outstanding(Mil.): 2,221.82
Dividend: 16.00
Yield (%): 2.03


  4503.T Industry Sector
P/E (TTM): 18.47 31.28 37.85
EPS (TTM): 85.48 -- --
ROI: 13.23 14.74 14.09
ROE: 13.77 15.31 14.83
Search Stocks

Japan's Astellas looking for more deals to refuel drug pipeline

LONDON Japan's Astellas is seeking more deals to refill its drug pipeline as the pharmaceutical company created through a merger 10 years ago explores opportunities in both established and new therapy areas.

14 Oct 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
Provider : GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks